Media

Registration for this year’s Livestock Biotech Summit is officially open to attendees and credentialed media, the Biotechnology Industry Organization (...
selective group of CEOs and COOs from emerging industrial biotechnology companies will present new technologies, accomplishments, and business cases during...

Press Releases

Jan 27 2000
WASHINGTON, D.C. (Jan. 27, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement on Medicare...
Jan 21 2000
WASHINGTON, D.C. (Jan. 21, 1999) Not too long ago, the idea of treating the root causes of diseases was just that, an idea. And so was the prospect of feeding...
Jan 20 2000
CEO & Investor Conference To Showcase Industry To New Investors WASHINGTON, D.C. (January 20, 2000) Recent gains inbiotechnology stocks have rivaled the...
Jan 18 2000
WASHINGTON, D.C. (January 14, 2000) A BIO-sponsored television ad will begin running Jan. 17 on cable and news talk shows throughout the Washington...
Jan 18 2000
WASHINGTON, D.C. (Jan. 18, 2000) Another 22biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug...
Jan 11 2000
Washington, D.C. (January 11, 2000) The Biotechnology Industry Organization (BIO) will host its 14th International Biotechnology Meeting and Exhibition two...
Dec 20 1999
WASHINGTON, D.C. (Dec. 20, 1999) -- Dr. Judah Folkman, who discovered the process of tumor angiogenesis, and Dr. Jurgen Drews, former president of global...
Dec 7 1999
WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient...
Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6,...


Biotechnology News

April 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming...

April 23, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic...

April 23, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions will release 1Q 2014 financial results and conduct a conference call at May 8, 2014.

April 23, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceutical’s Pivotal Trial of Captisol-Enabled™ (Propylene Glycol-Free) Melphalan Meets Primary Endpoint

April 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to...